Domestic supply of GSK’s meningitis, ‘Hiberix,’ suspended
‘Hiberix,’ a meningitis vaccine, has been suspended in the domestic supply.
GSK, the supplier of the drug, decided to suspend the supply of Hiberix as adopting ‘Vaxem-Hib,’ another meningitis vaccine, through the last year’s acquisition of the Novartis’s vaccine department.
‘Hiberix’ is a produ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
